Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 7, Number 6—December 2001

Legionella-Like and Other Amoebal Pathogens as Agents of Community-Acquired Pneumonia

Thomas J. Marrie*Comments to Author , Didier Raoult†, Bernard La Scola†, Richard J. Birtles†, Emidio de Carolis‡, and the Canadian Community-Acquired Pneumonia Study Group
Author affiliations: *Department of Medicine University of Alberta, Edmonton, Alberta, Canada;; †Faculté de Médecine de Marseille, Marseille, France;; ‡Pfizer Canada Inc., Montreal, Quebec, Canada

Main Article

Table 1

Percent seropositivity (antibody titer ³1:50) to various antigens among three study groupsa

Antigen Healthy Nova Scotians (%)
N = 511 Ambulatory Pneumonia (%)
N = 121 CAP requiring Hospitalization (%)
N = 255
LLAP-1 0.19 1.6 0.7
LLAP-2 0 0 0.39
LLAP-3 0.39 1.6 0.7
LLAP-4 0.39 0 4.3
LLAP-6 0.1 0 0.39
LLAP-7 1.36 0 1.56
LLAP-9 0.39 1.6 0.7
LLAP-10 0 0 0.7
LLAP-12 0.97 1.6 0.39
Hall's coccus 0 1.6 2.35
BN 9 0 0 2.35
Afipia felis

aAs defined in paper.
CAP = community-acquired pneumonia.

Main Article

1R. Duperval, S. Field, T. Louie, S. Houston, M. Gribble, K. Williams, L. Nicolle, R. Grossman, I. Salit, R. Saginur, D. Gregson, M. Laverdiere, Jean Joly, T. Marrie, and J. Hutchinson.

Page created: December 09, 2010
Page updated: December 09, 2010
Page reviewed: December 09, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.